| GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|
| EPCAM | 11529 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by FACs and qRT-PCR | NA | 0.32 | 0.211 | 27773936
|
| EPCAM | 11529 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | CFA followed by SFA and qRT-PCR | NA | 0.32 | 0.211 | 27783993
|
| EPCAM | 11529 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by qRT-PCR | NA | 0.32 | 0.211 | 25676692
|
| EPCAM | 11529 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | FACs followed by CFA | NA | 0.32 | 0.211 | 22194816
|
| PROM1 | 9454 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by FACs and qRT-PCR | NA | 0.32 | 0.7582 | 27773936
|
| PROM1 | 9454 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | CFA followed by SFA and qRT-PCR | NA | 0.32 | 0.7582 | 27783993
|
| PROM1 | 9454 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | FACs followed by CFA | NA | 0.32 | 0.7582 | 22194816
|
| PROM1 | 9454 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by FACs | NA | 0.32 | 0.7582 | 25676692
|
| ABCF1 | 70 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | Western Blotting followed by CFA | NA | 0.28 | 0.0011 | 31100412
|
| CD24 | 1645 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | NA | 0.24 | 0.456 | 25676692
|
| CD24 | 1645 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.24 | 0.456 | 26259570
|
| DHCR7 | 2860 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0064 | 25676692
|
| DHCR7 | 2860 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.24 | 0.0064 | 26259570
|
| FASN | 3594 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0074 | 25676692
|
| FASN | 3594 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.24 | 0.0074 | 26259570
|
| HMGCS1 | 5007 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | NA | 0.24 | 0.0074 | 25676692
|
| HMGCS1 | 5007 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | NA | 0.24 | 0.0074 | 25676692
|
| HMGCS1 | 5007 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.24 | 0.0074 | 26259570
|
| IGFBP3 | 5472 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | NA | 0.24 | 0.0095 | 25676692
|
| IGFBP3 | 5472 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | NA | 0.24 | 0.0095 | 25676692
|
| IGFBP3 | 5472 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.24 | 0.0095 | 26259570
|
| MIR100 | 31487 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0032 | 25676692
|
| MIR1269B | 41787 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | Down | 0.24 | 0.0011 | 25676692
|
| MIR1269B | 41787 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | Down | 0.24 | 0.0011 | 25676692
|
| MIR15B | 31544 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0085 | 25676692
|
| MIR210 | 31587 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0064 | 25676692
|
| MIR215 | 31592 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | Down | 0.24 | 0.0021 | 25676692
|
| MIR22 | 31599 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0021 | 25676692
|
| MVD | 7529 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0042 | 25676692
|
| MVD | 7529 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.24 | 0.0042 | 26259570
|
| NDGG1 | NA | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | NA | 0.24 | 0.0011 | 25676692
|
| NDGG1 | NA | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | NA | 0.24 | 0.0011 | 25676692
|
| ODC1 | 8109 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0021 | 25676692
|
| ODC1 | 8109 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.24 | 0.0021 | 26259570
|
| TGFB1 | 11766 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | NA | 0.24 | 0.0138 | 25676692
|
| TGFB1 | 11766 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | NA | 0.24 | 0.0138 | 25676692
|
| CD24 | 1645 | HTM/LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | NA | 0.24 | 0.456 | 25676692
|
| DHCR7 | 2860 | HTM/LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0064 | 25676692
|
| FASN | 3594 | HTM/LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0074 | 25676692
|
| HMGCS1 | 5007 | HTM/LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | NA | 0.24 | 0.0074 | 25676692
|
| IGFBP3 | 5472 | HTM/LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | NA | 0.24 | 0.0095 | 25676692
|
| MIR100 | 31487 | HTM/LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0032 | 25676692
|
| MIR1269A | 35337 | HTM/LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | Down | 0.24 | 0.0011 | 25676692
|
| MIR1269B | 41787 | HTM/LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | Down | 0.24 | 0.0011 | 25676692
|
| MIR15B | 31544 | HTM/LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0085 | 25676692
|
| MIR210 | 31587 | HTM/LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0064 | 25676692
|
| MIR215 | 31592 | HTM/LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | Down | 0.24 | 0.0021 | 25676692
|
| MIR22 | 31599 | HTM/LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0021 | 25676692
|
| MVD | 7529 | HTM/LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0042 | 25676692
|
| NDGG1 | NA | HTM/LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | NA | 0.24 | 0.0011 | 25676692
|
| ODC1 | 8109 | HTM/LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0021 | 25676692
|
| TGFB1 | 11766 | HTM/LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | NA | 0.24 | 0.0138 | 25676692
|
| NANOG | 20857 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.5461 | 34405006
|
| NANOG | 20857 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | CFA followed by SFA and qRT-PCR | NA | 0.2 | 0.5461 | 27783993
|
| NANOG | 20857 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.5461 | 25676692
|
| NANOG | 20857 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | FACs followed by CFA | NA | 0.2 | 0.5461 | 22194816
|
| POU5F1 | 9221 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.6448 | 27773936
|
| POU5F1 | 9221 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.6448 | 34405006
|
| POU5F1 | 9221 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | CFA followed by SFA and qRT-PCR | NA | 0.2 | 0.6448 | 27783993
|
| POU5F1 | 9221 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.6448 | 25676692
|
| POU5F1 | 9221 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | FACs followed by CFA | NA | 0.2 | 0.6448 | 22194816
|
| SOX2 | 11195 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.5695 | 27773936
|
| SOX2 | 11195 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.5695 | 34405006
|
| SOX2 | 11195 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | CFA followed by SFA and qRT-PCR | NA | 0.2 | 0.5695 | 27783993
|
| SOX2 | 11195 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | FACs followed by CFA | NA | 0.2 | 0.5695 | 22194816
|
| THY1 | 11801 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | CFA followed by SFA and qRT-PCR | NA | 0.2 | 0.0371 | 27783993
|
| THY1 | 11801 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0371 | 25676692
|
| THY1 | 11801 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | FACs followed by CFA | NA | 0.2 | 0.0371 | 22194816
|
| ABCB5 | 46 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | FACs followed by CFA | NA | 0.12 | 0.0085 | 22194816
|
| ABCC1 | 51 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | FACs followed by CFA | NA | 0.12 | 0.0212 | 22194816
|
| ALDH1A2 | 15472 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | ALDEFLUOR assay | NA | 0.12 | 0.0117 | 34405006
|
| CD44 | 1681 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | FACs followed by CFA | NA | 0.12 | 1 | 22194816
|
| CD44 | 1681 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by FACs | NA | 0.12 | 1 | 25676692
|
| CTNNB1 | 2514 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | FACs followed by CFA | NA | 0.12 | 0.0647 | 22194816
|
| GRN | 4601 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | FACs followed by CFA | NA | 0.12 | 0.0032 | 22194816
|
| A1CF | 24086 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| ABCA5 | 35 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| ABCA9 | 39 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| ABCC6P1 | 33352 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| ABHD3 | 18718 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| ABLIM3 | 29132 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| ACSL4 | 3571 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| ACTR6 | 24025 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| ADAMTS6 | 222 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| ADCY10 | 21285 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| ADPRM | 30925 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| AFDN-DT | 21236 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| AFP | 317 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| AGAP5 | 23467 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| AGAP6 | 23466 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| AGR2 | 328 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0064 | 26259570
|
| AHSA2P | 20437 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| AK9 | 33814 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| AKR1D1 | 388 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| ALAD | 395 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| ALDOC | 418 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570
|
| ALG10B | 31088 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| ALPL | 438 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| AMDHD1 | 28577 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| AMPD3 | 470 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| ANGPTL4 | 16039 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| ANKRD49 | 25970 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| ANO1 | 21625 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| ANXA3 | 541 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0085 | 26259570
|
| ANXA4 | 542 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| ARG1 | 663 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| ARG2 | 664 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570
|
| ARGLU1 | 25482 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| ARHGEF16 | 15515 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
| ARHGEF25 | 30275 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| ARMCX3 | 24065 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| ATP2B2 | 815 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| ATP6V1B1 | 853 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| B3GNT5 | 15684 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| BAIAP2L2 | 26203 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| BBIP1 | 28093 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| BCAS1 | 974 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| BCL6 | 1001 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| BEX1 | 1036 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| BMF | 24132 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| BOP1 | 15519 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
| BVES | 1152 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| C14ORF132 | 20346 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| C1D | 29911 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| C1R | 1246 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| C1S | 1247 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| C2ORF88 | 28191 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| C3 | 1318 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 26259570
|
| C4ORF33 | 27025 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| C8ORF4 | 25646 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25676692
|
| C8ORF4 | 25646 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25676692
|
| C8ORF4 | 25646 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| CA9 | 1383 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| CAD | 1424 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570
|
| CALCOCO1 | 29306 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| CAMK1 | 1459 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| CAV1 | 1527 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0117 | 26259570
|
| CAV2 | 1528 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 26259570
|
| CBWD3 | 18519 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| CCDC198 | 20189 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| CCDC80 | 30649 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| CCDC92 | 29563 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| CCT6P1 | 33094 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| CD58 | 1688 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| CDH12 | 1751 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| CDK14 | 8883 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| CDKN2B-AS1 | 34341 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| CFAP251 | 28506 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| CFAP44 | 25631 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| CFI | 5394 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| CHP2 | 24927 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| CITED2 | 1987 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25676692
|
| CITED2 | 1987 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25676692
|
| CITED2 | 1987 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570
|
| CLDN4 | 2046 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 26259570
|
| CLDN5 | 2047 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| CLHC1 | 26453 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| CLIP3 | 24314 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| CLK1 | 2068 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| CNTD1 | 26847 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| CNTNAP1 | 8011 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| COL6A2 | 2212 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| CPM | 2311 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 26259570
|
| CREB3L3 | 18855 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| CRLS1 | 16148 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| CRYGS | 2417 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| CSAD | 18966 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| CSRP1 | 2469 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| CSRP2 | 2470 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| CTSZ | 2547 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| CUTC | 24271 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570
|
| CUX2 | 19347 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| CXCL12 | 10672 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| CYFIP2 | 13760 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| CYGB | 16505 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| CYP27C1 | 33480 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| CYP3A7 | 2640 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| CYP4V2 | 2640 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| CYTH1 | 23198 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| DAPK1 | 2674 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570
|
| DENND10 | 31793 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| DEPP1 | 23355 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| DFNA5 | 2674 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| DFNB59 | 2810 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| DLX6-AS1 | 37151 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| DNAH11 | 2942 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| DNAJC28 | 1297 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| DPYD | 3012 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| DSE | 21144 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| DTNA | 3057 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570
|
| DUS3L | 26920 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| DUSP1 | 3064 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| DUSP10 | 3065 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| EEF1A2 | 3192 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| EEF2KMT | 32221 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| EFEMP1 | 3218 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0064 | 26259570
|
| EFNA1 | 3221 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| EGFL8 | 13944 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| EGLN3 | 14661 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| EID3 | 32961 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| ELOVL2 | 14416 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570
|
| ELOVL7 | 26292 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| EML6 | 35412 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| ENPP1 | 3356 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| EPHA1 | 3385 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
| EPO | 3415 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| ESYT3 | 24295 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| ETAA1 | 24648 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| ETFRF1 | 27052 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| ETV4 | 3493 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570
|
| FADS2 | 3575 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0064 | 25676692
|
| FADS2 | 3575 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0064 | 25676692
|
| FADS2 | 3575 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0064 | 26259570
|
| FAM13B | 1335 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| FAM200B | 27740 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| FAM214A | 25609 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| FAM229B | 33858 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| FAM43A | 26888 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| FAM76A | 28530 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| FBXL21P | 13600 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| FBXO8 | 13587 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| FBXW9 | 28136 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| FDFT1 | 3629 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25676692
|
| FDFT1 | 3629 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25676692
|
| FDFT1 | 3629 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 26259570
|
| FGF11 | 3667 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| FGF12 | 3668 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| FHOD3 | 26178 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570
|
| FLJ22536 | NA | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| FLVCR2 | 20105 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| FSCN1 | 11148 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0064 | 26259570
|
| FXYD3 | 4027 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 26259570
|
| FYB2 | 27295 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| FZD4 | 4042 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| G0S2 | 30229 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 26259570
|
| GABARAPL1 | 4068 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| GC | 4187 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| GCNT4 | 17973 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| GFRA3 | 4245 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| GHR | 4263 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| GJC2 | 17494 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| GOLGA8IP | 26660 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| GPR183 | 3128 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| GPX2 | 4554 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570
|
| GRAMD2B | 24911 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570
|
| GRIK4 | 4582 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| GSAP | 28042 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| GSDMB | 23690 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| GUSBP1 | 13670 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| H19 | 4713 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 26259570
|
| HABP2 | 4798 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25676692
|
| HABP2 | 4798 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25676692
|
| HABP2 | 4798 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570
|
| HAVCR1 | 17866 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| HCAR2 | 24827 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| HES6 | 18254 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
| HGH1 | 24161 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| HHLA2 | 4905 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| HIF3A | 15825 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| HIST1H1E | 4718 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| HLF | 4977 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| HMGCR | 5006 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 26259570
|
| HMGCS2 | 5008 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| HPD | 5147 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25676692
|
| HPD | 5147 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25676692
|
| HPD | 5147 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570
|
| HSPB8 | 30171 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| HTR2B | 5294 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| HTRA4 | 26909 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| HULC | 34232 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| HYAL1 | 5320 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25676692
|
| HYAL1 | 5320 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25676692
|
| HYAL1 | 5320 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570
|
| ID1 | 5360 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25676692
|
| ID1 | 5360 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25676692
|
| ID1 | 5360 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 26259570
|
| ID2 | 5361 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 26259570
|
| ID4 | 5363 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570
|
| IFI6 | 4054 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| IFIT2 | 5409 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| IFTAP | 25142 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| IGF2 | 5466 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| IGF2BP2-AS1 | 32674 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| IGFBP1 | 5469 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| IGLL3P | 5872 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| IKBIP | 26430 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| IL1R1 | 5993 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| IL8 | 6025 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0159 | 26259570
|
| INHA | 6065 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570
|
| INHBB | 6067 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 26259570
|
| INSIG2 | 20452 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| IRAK4 | 17967 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| ITGA2 | 6137 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0106 | 26259570
|
| ITGB3BP | 6157 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| ITPKA | 6178 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| JAK2 | 6192 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 26259570
|
| KBTBD11 | 29104 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| KCNAB2 | 6229 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| KCNF1 | 6246 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570
|
| KCNJ5 | 6266 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| KCNT2 | 18866 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| KIF5C | 6325 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| KISS1R | 4510 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| KLF6 | 2235 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| KLHDC2 | 20231 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| KMO | 6381 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| KMT2E-AS1 | 40845 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| KNG1 | 6383 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25676692
|
| KNG1 | 6383 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25676692
|
| KNG1 | 6383 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| L3HYPDH | 20488 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| L3MBTL1 | 15905 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| LAMC2 | 6493 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| LAMC3 | 6494 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
| LARP6 | 24012 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| LAS1L | 25726 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| LFNG | 6560 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| LGALS1 | 6561 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 26259570
|
| LGALS14 | 30054 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| LGI4 | 18712 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| LIG4 | 6601 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| LINC00261 | 16189 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| LINC02210 | 26327 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| LINC02249 | 32351 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| LINC-PINT | 26885 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| LIPC | 6619 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| LOX | 6664 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 25676692
|
| LOX | 6664 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 25676692
|
| LOX | 6664 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 26259570
|
| LOXL4 | 17171 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| LPIN2 | 14450 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| LRAT | 6685 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| LRP5L | 25323 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| LRRC37A3 | 32427 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| LRRC37BP1 | 25390 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| LRRC49 | 25965 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| LY6E | 6727 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570
|
| MAMDC4 | 24083 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| MAP3K6 | 6858 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| MAP3K8 | 6860 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| MBD4 | 6919 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| MBL2 | 6922 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| MCAM | 6934 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 26259570
|
| MCC | 6935 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| MCM7 | 6950 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570
|
| MCOLN3 | 13358 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| MEP1A | 7015 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| MIPOL1 | 21460 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| MIR149 | 31536 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25676692
|
| MIR149 | 31536 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25676692
|
| MIR181C | 31552 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25676692
|
| MIR181C | 31552 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25676692
|
| MIR199A1 | 31571 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25676692
|
| MIR199A1 | 31571 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25676692
|
| MIR199B | 31573 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25676692
|
| MIR199B | 31573 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25676692
|
| MIR22HG | 28219 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| MIR29C | 31621 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25676692
|
| MIR29C | 31621 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25676692
|
| MIR338 | 31775 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25676692
|
| MIR338 | 31775 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25676692
|
| MIR375 | 31868 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25676692
|
| MIR375 | 31868 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25676692
|
| MIR378A | 31871 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25676692
|
| MIR378A | 31871 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25676692
|
| MIR378D1 | 41550 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25676692
|
| MIR378D1 | 41550 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25676692
|
| MIR450B | 33642 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25676692
|
| MIR450B | 33642 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25676692
|
| MIR760 | 33666 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25676692
|
| MIR760 | 33666 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25676692
|
| MKKS | 7108 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| MMD | 7153 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| MOXD1 | 21063 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| MPZL2 | 3496 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 26259570
|
| MST1 | 7380 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| MST1L | 7390 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| MST1P2 | 7383 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| MTERFD3 | 30779 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| MTSS1 | 20443 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570
|
| MUC13 | 7511 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 26259570
|
| MYBBP1A | 7546 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570
|
| MYH3 | 7573 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| MYLK3 | 29826 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| N4BP2L2-IT2 | 25038 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| NAALADL1 | 23536 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| NAP1L5 | 19968 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| NAPB | 15751 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| NAPRT | 30450 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
| NAT1 | 7645 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| NAV2 | 15997 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570
|
| NAV3 | 15998 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570
|
| NCR3LG1 | 42400 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
| NDRG1 | 7679 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 26259570
|
| NEIL2 | 18956 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| NKAIN1 | 25743 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570
|
| NKD2 | 17046 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| NLE1 | 19889 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| NLRP8 | 22940 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| NOL6 | 19910 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
| NOP16 | 26934 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| NOX4 | 7891 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| NPC1L1 | 7898 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| NQO1 | 2874 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 26259570
|
| NR1H4 | 7967 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25676692
|
| NR1H4 | 7967 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25676692
|
| NR1H4 | 7967 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| NTN1 | 8029 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570
|
| NTN4 | 13658 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| NUAK1 | 14311 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| NYNRIN | 20165 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
| OAS1 | 8086 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570
|
| ORMDL3 | 16038 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| OVGP1 | 8524 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| P3H2 | 19317 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| PABPC1L | 15797 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| PANX2 | 8600 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| PAQR6 | 30132 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| PCDH17 | 14267 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| PCDHB16 | 14546 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| PCMTD2 | 15882 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| PDCD11 | 13408 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| PDE4C | 8782 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| PDE5A | 8784 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| PDGFRA | 8803 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| PDZK1 | 8821 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| PEX2 | 9717 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| PFAS | 8863 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
| PFDN4 | 8868 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| PFN1P2 | 24298 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| PGAM5 | 28763 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| PHKA2 | 8926 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| PHLDB2 | 29573 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| PID1 | 26084 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| PIEZO2 | 26270 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| PIK3IP1 | 24942 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| PITX1 | 9004 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| PKLR | 9020 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| PLA1A | 17661 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| PLA2G4C | 9037 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| PLCXD3 | 31822 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| PLEKHB1 | 19079 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| PLIN2 | 248 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 26259570
|
| PLOD2 | 9082 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 25676692
|
| PLOD2 | 9082 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 25676692
|
| PLOD2 | 9082 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 26259570
|
| PLSCR4 | 16497 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| PMFBP1 | 17728 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| POLR1E | 17631 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
| POLR3D | 1080 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| POP1 | 30129 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
| PPARGC1A | 9237 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| PPFIBP2 | 9250 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| PPP1R1C | 14940 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| PRG2 | 9362 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| PRICKLE2 | 20340 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| PRKAB2 | 9379 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| PRLR | 9446 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| PRODH | 9453 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
| PRR7 | 28130 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| PTHLH | 9607 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570
|
| PTP4A3 | 9636 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| PTPRH | 9672 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| PTPRM | 9675 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25676692
|
| PTPRM | 9675 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25676692
|
| PTPRM | 9675 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| PUS1 | 15508 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
| RALB | 9840 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| RALGPS1 | 16851 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| RARB | 9865 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| RASL11A | 23802 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| RASSF5 | 17609 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| RBM43 | 24790 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| RECQL4 | 9949 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
| RGL4 | 31911 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| RHOB | 668 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570
|
| RIN1 | 18749 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| RNF217 | 21487 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| RNF7 | 10070 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| ROBO2 | 10250 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| RRP12 | 29100 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| RRP9 | 16829 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
| RTN4R | 18601 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| RWDD2A | 21385 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| RWDD3 | 21393 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| S100A11 | 10488 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570
|
| SCARNA9 | 32566 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| SCN2A | 10588 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| SCRIB | 30377 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| SECTM1 | 10707 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| SELENBP1 | 10719 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570
|
| SEMA3F | 10728 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| SEMA7A | 10741 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| SEPHS2 | 19686 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| SEPTIN7P2 | 32339 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| SERPINA5 | 8723 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| SERPINF1 | 8824 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| SERPING1 | 1228 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25676692
|
| SERPING1 | 1228 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25676692
|
| SERPING1 | 1228 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| SFN | 10773 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 25676692
|
| SFN | 10773 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 25676692
|
| SFN | 10773 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 26259570
|
| SH2D5 | 28819 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
| SLC1A3 | 10941 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570
|
| SLC22A15 | 20301 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| SLC22A23 | 21106 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| SLC25A47 | 20115 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| SLC2A12 | 18067 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| SLC2A2 | 11006 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| SLC30A10 | 25355 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| SLC39A4 | 17129 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| SLC43A2 | 23087 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25676692
|
| SLC43A2 | 23087 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25676692
|
| SLC43A2 | 23087 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570
|
| SLC5A11 | 23091 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
| SLC6A12 | 11045 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570
|
| SLC6A14 | 11047 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| SLC6A20 | 30927 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| SLC7A5 | 11063 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 26259570
|
| SLCO4A1 | 10953 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 26259570
|
| SMAD7 | 6773 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| SMIM24 | 37244 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| SNAP25 | 11132 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| SNHG6 | 32965 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| SOCS2 | 19382 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 26259570
|
| SORL1 | 11185 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| SP8 | 19196 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| SPACA6 | 27113 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| SPDYE1 | 16408 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| SPTBN2 | 11276 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| SQLE | 11279 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 26259570
|
| SREBF2 | 11290 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| SSTR5 | 11334 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| ST20 | 33520 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| ST3GAL6 | 18080 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| ST6GAL1 | 10860 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| STARD8 | 19161 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
| STBD1 | 24854 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| STK33 | 14568 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| SUSD1 | 25413 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| SYBU | 26011 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| SYNE3 | 19861 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| SYNE4 | 26703 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
| TANC2 | 30212 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| TCOF1 | 11654 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570
|
| TCP11L2 | 28627 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| TEDC1 | 20127 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
| TF | 11740 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| TFF3 | 11757 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 26259570
|
| TGFB2 | 11768 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 26259570
|
| TGFBI | 11771 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| THAP6 | 23189 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| THBS1 | 11785 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570
|
| THBS4 | 11788 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| THSD4 | 25835 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| TIAM2 | 11806 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| TINAGL1 | 19168 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| TKT | 11834 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 26259570
|
| TM2D3 | 24128 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| TM4SF4 | 11856 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| TMED10P1 | 30754 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| TMEM263 | 28281 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| TMEM51 | 25488 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| TMEM82 | 32350 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| TMEM97 | 28106 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570
|
| TNFAIP3 | 11896 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 26259570
|
| TNFSF4 | 11934 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| TNNT1 | 11948 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| TNS1 | 11973 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25676692
|
| TNS1 | 11973 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25676692
|
| TNS1 | 11973 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| TONSL | 7801 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
| TOR4A | 25981 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| TP53INP1 | 18022 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| TPM1 | 12010 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570
|
| TPRKB | 24259 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| TRAPPC9 | 30832 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| TRIM15 | 16284 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25676692
|
| TRIM15 | 16284 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25676692
|
| TRIM15 | 16284 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
| TRIM31 | 16289 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| TRIM58 | 24150 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| TTC39C | 26595 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| TXNDC9 | 24110 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| UBD | 18795 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| UCA1 | 37126 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| UGT1A1 | 12530 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
| UGT1A6 | 12538 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570
|
| UGT2B10 | 12544 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| UNC80 | 26582 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| USP49 | 20078 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| VAV3 | 12659 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| VEPH1 | 25735 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| VN1R2 | 19872 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| VNN3 | 16431 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| WDR5B | 17826 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| WDR72 | 26790 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| WDSUB1 | 26697 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| WHAMMP2 | 32360 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| WSB2 | 19222 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| XRCC3 | 12830 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
| YAF2 | 17363 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| ZBTB18 | 13030 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| ZCCHC9 | 25424 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| ZDHHC13 | 18413 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| ZDHHC2 | 18469 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| ZIC4 | 20393 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| ZNF124 | 12907 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| ZNF140 | 12925 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| ZNF189 | 12980 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| ZNF212 | 13004 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
| ZNF277 | 13070 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| ZNF287 | 13502 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| ZNF302 | 13848 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| ZNF331 | 15489 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| ZNF334 | 15806 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| ZNF354C | 16736 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| ZNF432 | 20810 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| ZNF614 | 24722 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
| ZNF649 | 25741 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
| ZNF69 | 13138 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| ZNF75D | 13145 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
| ZNF814 | 33258 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|